An international expert panel introduces the first consensus recommendations for diagnosing and treating chronic non-bacterial osteitis (CNO) in adults - consolidating multiple disease labels into a single entity and establishing evidence-based protocols.
The 2025 immunization guidelines marked a shift from quadrivalent to trivalent influenza vaccines, introduced new RSV timing protocols, and revised multiple vaccination schedules, including meningococcal B dosing for ages 16-23 years.